Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) and Netra Restoration Therapy

Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) and Netra Restoration Therapy

Non-Arteritic Anterior Ischemic Optic Neuropathy, often abbreviated as NAION, is a sudden ischemic injury of the front portion of the optic nerve. Patients often describe it as waking up with blurred, dim, missing, or distorted vision in one eye. It is usually painless and may involve central vision, peripheral vision, color perception, contrast sensitivity, or a combination of these visual functions.

NAION is sometimes called an 'optic nerve stroke,' although that phrase is not a perfect medical description. The key issue is reduced blood flow and oxygen delivery to the optic nerve head. The optic nerve is the cable that carries visual information from the eye to the brain. When the front part of the optic nerve becomes ischemic, nerve fibers can swell, blood flow can become further compromised, and retinal ganglion cell axons may become vulnerable to permanent injury.

The most widely accepted model describes NAION as a multifactorial event. A structurally crowded optic nerve head, often called a 'disc at risk,' may make the nerve more susceptible to a drop in perfusion. Systemic vascular factors such as diabetes, hypertension, high cholesterol, smoking, obstructive sleep apnea, nocturnal hypotension, anemia, cardiovascular disease, and impaired autoregulation can add further stress. In many patients, the episode is not explained by one factor alone.

Netra Restoration Therapy, or NRT, is a full-spectrum integrative ophthalmology platform designed to support the biological terrain that influences optic nerve health. For NAION, NRT does not claim to reopen a blocked vessel, reverse established optic nerve infarction, or replace urgent neuro-ophthalmic evaluation. Instead, it is positioned as an adjunctive and supportive approach that focuses on the key drivers of optic nerve vulnerability: ocular perfusion, vascular regulation, mitochondrial function, oxidative stress, inflammation, retinal ganglion cell resilience, neurotrophin biology, autonomic balance, sleep-related oxygenation, and systemic vascular risk.

This distinction matters. NAION can be sudden, serious, and emotionally distressing. Patients need appropriate eye examination and medical evaluation, especially to rule out arteritic anterior ischemic optic neuropathy related to giant cell arteritis, which is an emergency. Once appropriate medical evaluation is in place, many patients still ask an important long-term question: how can the remaining optic nerve tissue and the unaffected eye be supported? NRT is designed to address that broader question.

A Comprehensive Therapy Designed to Support the Key Underlying Drivers of NAION

Netra Restoration Therapy views NAION through a systems biology lens. The optic nerve head is not isolated tissue. It depends on steady blood flow, healthy endothelial function, adequate oxygen delivery, mitochondrial energy production, inflammatory balance, and neurotrophic support. It is also influenced by whole-body physiology: blood pressure patterns, glucose regulation, sleep quality, vascular stiffness, autonomic tone, stress physiology, anemia, metabolic inflammation, and cardiometabolic health.

In conventional clinical care, NAION is often diagnosed through history, optic disc examination, visual field testing, optical coherence tomography, and exclusion of other causes of optic nerve swelling. That structural and diagnostic work is essential. NRT adds another layer: it asks what biological conditions made the optic nerve vulnerable and what can be done to support the optic nerve terrain after the event.

The NRT model for NAION focuses on multiple interacting targets:

• Supporting optic nerve head perfusion and microcirculatory health.
• Improving the systemic vascular terrain that affects ocular perfusion pressure.
• Supporting endothelial function and vascular autoregulation.
• Reducing oxidative stress that may worsen retinal ganglion cell injury.
• Supporting mitochondrial energy production in optic nerve and retinal ganglion cell tissue.
• Encouraging inflammatory balance after ischemic stress.
• Supporting neurotrophin-related pathways, including BDNF and NGF biology.
• Addressing sleep-related hypoxia and autonomic imbalance when clinically relevant.
• Supporting whole-person metabolic resilience, including glucose, lipids, blood pressure rhythm, and systemic inflammation.

Traditional Chinese Medicine and Ayurvedic concepts may also be used within NRT, but they are not presented as vague 'alternative' explanations. They are translated into modern physiological language when possible. A TCM pattern such as Blood Stasis may be interpreted as a clinical framework that overlaps with impaired microcirculation, vascular congestion, endothelial dysfunction, or poor tissue perfusion. Qi Deficiency may be used as a traditional pattern that roughly parallels reduced metabolic reserve, fatigue, impaired repair capacity, or poor systemic resilience. Ayurvedic concepts such as Vata disturbance may be interpreted as a framework involving nervous system instability, dryness, stress reactivity, and irregular circulation. These are conceptual parallels, not exact biomedical equivalents.

NRT is therefore not a single intervention. It is a multi-modal platform that may include acupuncture-based ocular support, traditional herbal medicine interpreted through network pharmacology, nutrition, mitochondrial support, vascular and autonomic assessment, sleep and stress physiology review, and functional medicine-style evaluation of systemic terrain. The goal is to support the optic nerve as living neural tissue that remains biologically responsive to its environment.

Why Treatment Support for NAION Should Be Multi-Factorial

NAION is usually described as ischemic injury to the optic nerve head, but ischemia itself is the final common event. The conditions that lead to reduced optic nerve perfusion can differ from patient to patient. One patient may have diabetes and sleep apnea. Another may have nocturnal hypotension and a crowded optic disc. Another may have vascular stiffness, smoking history, anemia, or impaired autoregulation. A narrow approach misses this complexity.

A multi-factorial approach is especially important because the optic nerve has limited tolerance for oxygen deprivation. Once axons are injured, the downstream retinal ganglion cells may undergo apoptosis and neurodegeneration. Supporting the tissue environment requires more than one target.

Optic Nerve Head Hypoperfusion

The central biological event in NAION is reduced blood flow to the optic nerve head. Reviews such as Miller and Arnold's Eye paper describe NAION as presumed circulatory insufficiency within the optic nerve head, although the exact vascular location and mechanism remain incompletely proven. The optic nerve head is supplied largely by branches of the posterior ciliary circulation. If perfusion drops below the tissue's needs, ischemia and swelling can follow.

For NRT, this makes ocular perfusion a primary target. Supportive care may include attention to systemic circulation, endothelial health, blood pressure rhythm, stress physiology, and vascular risk factors. The emphasis is not on one narrow vessel, but on the vascular environment that determines whether the optic nerve receives stable oxygen and nutrient delivery.

Crowded Optic Disc and Compartment-Like Stress

Many NAION patients have a small cup-to-disc ratio or a crowded optic nerve head, often called a disc at risk. In this setting, ischemic swelling may create a vicious cycle: swelling further compresses neighboring axons and capillaries within a limited space, which can worsen hypoxia and nerve fiber injury. StatPearls describes this as a compartment-like mechanism in which swelling inside a crowded scleral canal contributes to retinal ganglion cell axonal damage.

NRT cannot change the anatomy of a crowded disc. However, it can focus on modifiable terrain factors that may affect optic nerve vulnerability, such as perfusion, inflammation, oxidative stress, vascular stability, and metabolic resilience.

Nocturnal Hypotension and Perfusion Pressure

Many patients notice NAION upon awakening, which has led researchers to investigate nighttime perfusion, nocturnal hypotension, and sleep-related oxygenation. Ocular perfusion pressure depends partly on systemic blood pressure and intraocular pressure. If blood pressure drops too low during sleep, especially in a patient with a crowded disc or vascular disease, optic nerve perfusion may become vulnerable.

This is a major reason NAION should not be viewed only as an eye condition. The optic nerve may be affected by blood pressure timing, cardiovascular regulation, autonomic balance, hydration status, sleep quality, and medication timing. NRT emphasizes discussion with appropriate medical professionals rather than making unsupervised changes. The integrative question is: does the patient's systemic rhythm create a low-perfusion window for the optic nerve?

Obstructive Sleep Apnea and Intermittent Hypoxia

Obstructive sleep apnea is one of the most important systemic associations in NAION. Sleep apnea can produce intermittent hypoxia, oxidative stress, endothelial dysfunction, sympathetic activation, and blood pressure instability. A 2016 meta-analysis found that obstructive sleep apnea was a strong independent risk factor for NAION. Later reviews have continued to emphasize the association between sleep-disordered breathing and ocular vascular disease.

NRT considers sleep and breathing physiology part of optic nerve terrain. When symptoms suggest snoring, witnessed apneas, morning headaches, daytime sleepiness, resistant hypertension, or nighttime oxygen drops, patients should be encouraged to discuss sleep evaluation with their physician. Supporting the optic nerve cannot ignore overnight oxygen delivery.

Systemic Vascular and Metabolic Risk

Diabetes, hypertension, hyperlipidemia, cardiovascular disease, smoking, and obesity are frequently reported risk factors. A 2021 systematic review and meta-analysis in Frontiers in Medicine found significant associations between NAION and factors such as male sex, hypertension, hyperlipidemia, diabetes, coronary heart disease, sleep apnea, and medication history of cardiovascular drugs. These associations do not mean every patient has the same risk pattern, but they reinforce the need for whole-person vascular review.

NRT emphasizes this systemic terrain. Glucose variability, insulin resistance, lipid oxidation, endothelial dysfunction, vascular stiffness, inflammation, and impaired nitric oxide signaling may all influence optic nerve perfusion and resilience. The eye often reveals vascular stress that is occurring throughout the body.

Oxidative Stress and Mitochondrial Strain

Ischemia can create oxidative stress. When oxygen delivery is reduced and then restored unevenly, mitochondria may generate reactive oxygen species. Retinal ganglion cells are energy-demanding neurons, and their axons require mitochondrial support for signal transmission and survival. Reviews on retinal ganglion cell degeneration identify oxidative stress and mitochondrial dysfunction as major mechanisms in optic neuropathies, including ischemic optic neuropathy.

NRT therefore considers antioxidant capacity and mitochondrial support central to NAION terrain care. This may involve nutrition, metabolic stabilization, sleep restoration, reduction of systemic inflammatory burden, and botanical or traditional approaches studied for antioxidant and neuroprotective mechanisms. Evidence quality varies by intervention, so claims must remain cautious and support-focused.

Neuroinflammation and Glial Response

After ischemic stress, the optic nerve and retina can mount an inflammatory response. Glial cells, microglia, cytokine signaling, oxidative stress, and blood-retinal barrier disruption may all influence the secondary injury environment. Experimental anterior ischemic optic neuropathy models have been used to study retinal ganglion cell loss, oxidative stress, and neuroinflammation. These models are not the same as human clinical proof, but they help explain why supportive care should include inflammatory balance.

The NRT approach is not to suppress immunity indiscriminately. The goal is to support a balanced repair environment, reduce chronic inflammatory burden, and improve the cellular conditions under which surviving retinal ganglion cells and axons function.

Neurotrophin Deprivation and Retinal Ganglion Cell Vulnerability

Retinal ganglion cells depend on neurotrophic support. Brain-derived neurotrophic factor, or BDNF, and nerve growth factor, or NGF, are among the best-studied neurotrophins in optic nerve biology. Experimental optic nerve injury research has shown that BDNF can support retinal ganglion cell survival in animal models. Human clinical translation is still challenging, but neurotrophin biology remains central to neuroprotection research.

NRT includes neurotrophic support as a core concept. This does not mean that a supplement or herb can simply replace BDNF. Rather, the broader care plan seeks to support the cellular environment associated with neurotrophin signaling, mitochondrial health, blood flow, inflammation resolution, and neural resilience.

Key Biological Mechanisms in NAION

Reduced Posterior Ciliary Circulation

The anterior optic nerve head receives much of its blood supply from the posterior ciliary circulation. In NAION, disruption of this circulation or failure of autoregulation can reduce oxygen and nutrient delivery. This can trigger optic disc swelling, axonal transport disturbance, and retinal ganglion cell injury.

Axonal Swelling and Impaired Axonal Transport

Optic nerve axons carry visual information from retinal ganglion cells to the brain. After ischemia, axonal transport may become impaired. Swelling at the optic nerve head can further compress axons and small vessels, creating a self-reinforcing cycle of hypoxia and nerve fiber injury.

Retinal Ganglion Cell Apoptosis

The axons affected in NAION belong to retinal ganglion cells. When axonal injury is severe, the cell body may undergo apoptosis, a regulated form of cell death. This is why NAION is not only a vascular event; it is also a neurodegenerative event affecting retinal ganglion cell survival.

Ocular Perfusion Pressure Instability

Ocular perfusion pressure reflects the pressure gradient that helps drive blood flow into ocular tissues. It can be affected by systemic blood pressure, intraocular pressure, vascular resistance, and autoregulation. In patients vulnerable to NAION, unstable perfusion pressure may contribute to risk.

Endothelial Dysfunction and Vascular Autoregulation

Healthy blood vessels adjust diameter and flow according to tissue demand. Endothelial dysfunction can reduce this adaptive capacity. Diabetes, hypertension, sleep apnea, smoking, chronic inflammation, and oxidative stress can all impair endothelial signaling. For NAION, impaired autoregulation may help explain why the optic nerve head becomes vulnerable during periods of low perfusion or hypoxia.

Hypoxia and HIF Signaling

Hypoxia occurs when tissue oxygen delivery is insufficient. Hypoxia-inducible factors, or HIF pathways, help cells respond to low oxygen, but persistent or severe hypoxia may worsen oxidative stress, inflammation, and neuronal injury. NAION can be understood partly as a failure of oxygen delivery to a vulnerable optic nerve head.

Oxidative Stress

Oxidative stress occurs when reactive oxygen species exceed the tissue's antioxidant defenses. In optic neuropathies, oxidative stress can damage mitochondrial membranes, DNA, proteins, lipids, and axonal structures. For NAION, oxidative stress is especially relevant because ischemia and reperfusion-like processes can increase free radical burden.

Mitochondrial Dysfunction

Mitochondria are essential for retinal ganglion cell energy production. When mitochondrial function declines, neurons have less capacity to recover from ischemic stress. Mitochondrial dysfunction may also amplify reactive oxygen species, inflammatory signaling, and apoptosis pathways.

Neuroinflammation

Inflammatory signaling after ischemic injury can worsen tissue stress. Microglial activation, cytokine production, and glial remodeling may affect retinal ganglion cell survival. This is one reason a supportive plan for NAION should include inflammatory terrain and not only circulation.

Excitotoxicity

Excitotoxicity refers to injury caused by excessive stimulation of neurons, often involving glutamate signaling and calcium overload. While excitotoxicity is better studied in other optic nerve and retinal ischemia models, it is biologically plausible in ischemic neural injury. It remains an emerging mechanism rather than a fully defined NAION treatment target.

Ferroptosis and Lipid Peroxidation

Ferroptosis is an iron-dependent form of regulated cell death involving lipid peroxidation. It is increasingly studied in retinal and optic nerve neurodegeneration. Direct NAION-specific evidence remains limited, but ischemic oxidative stress, lipid injury, and mitochondrial dysfunction make ferroptosis-related biology relevant to the broader discussion of retinal ganglion cell resilience.

Autonomic Dysfunction and Stress Physiology

Autonomic balance influences vascular tone, blood pressure variability, heart rate variability, sleep physiology, and microcirculation. In NAION, autonomic dysregulation may contribute indirectly by affecting nocturnal blood pressure patterns, vascular reactivity, and perfusion stability. NRT gives attention to this system because optic nerve circulation is dynamic, not static.

What Is Netra Restoration Therapy for NAION?

Netra Restoration Therapy is an integrative ophthalmology platform designed to support ocular health through multiple biological pathways at the same time. For NAION, the focus is optic nerve resilience after ischemic injury and reduction of terrain factors that may contribute to future vulnerability.

NRT may include individualized combinations of acupuncture-based ocular support, traditional herbal medicine, Ayurvedic principles, nutritional and mitochondrial support, vascular terrain evaluation, sleep and stress physiology review, functional medicine-style assessment, and whole-person lifestyle support. The plan is individualized because NAION does not arise from the same pattern in every patient.

A patient with diabetes, sleep apnea, and inflammatory metabolic markers requires a different emphasis than a patient with low nighttime blood pressure and a thin body habitus. A patient with high oxidative stress, smoking history, poor sleep, and vascular stiffness requires another emphasis. NRT is designed to map these overlapping contributors and support the optic nerve terrain accordingly.

NRT should not be described as a cure for NAION. It should not be presented as a replacement for urgent evaluation of sudden vision loss. It should not suggest that established optic nerve infarction can be guaranteed to reverse. A responsible integrative approach recognizes the seriousness of ischemic optic nerve injury while still asking how surviving tissue, systemic vascular health, and the fellow eye can be supported.

In the NRT model, NAION care is organized around five practical questions:

• Is the optic nerve receiving stable perfusion and oxygen delivery?
• Are systemic vascular factors making the optic nerve more vulnerable?
• Is sleep-related hypoxia or nocturnal blood pressure change contributing to risk?
• Are oxidative stress, mitochondrial strain, or inflammation reducing retinal ganglion cell resilience?
• Can neuroprotective and whole-person strategies improve the biological terrain in which the optic nerve functions?

How NRT Supports the Biological Terrain in NAION

Supporting Optic Nerve Blood Flow

The central terrain target in NAION is optic nerve perfusion. NRT approaches blood flow through microcirculation, endothelial function, autonomic balance, vascular tone, systemic blood pressure rhythm, hydration, and metabolic health. Acupuncture-based care is interpreted through both traditional and biomedical frameworks: traditionally as moving Qi and Blood; biologically as a possible modulator of autonomic tone, neurovascular signaling, local circulation, and inflammatory balance. Evidence in NAION remains limited, but a 2015 clinical study reported functional improvements in patients receiving acupuncture for NAION-related optic nerve damage. Because the study design and evidence base are limited, acupuncture should be presented as complementary support, not proven definitive therapy.

Supporting Endothelial and Microvascular Health

The endothelium is the inner lining of blood vessels. It helps regulate blood flow, vascular tone, clotting balance, and inflammation. Diabetes, hypertension, dyslipidemia, sleep apnea, and smoking can impair endothelial function. NRT supports this terrain by encouraging physician-guided management of vascular risks, nutrition patterns that reduce inflammatory burden, movement when appropriate, stress reduction, and targeted integrative support for circulation.

Supporting Sleep and Oxygenation Terrain

Sleep apnea is strongly associated with NAION. From an integrative perspective, sleep apnea is not simply a sleep disorder. It is a nightly pattern of oxygen instability, sympathetic activation, oxidative stress, endothelial dysfunction, and blood pressure fluctuation. NRT screening may ask about snoring, witnessed pauses in breathing, morning headaches, fatigue, nighttime urination, and high blood pressure. Patients with risk signs should be referred to appropriate medical professionals for evaluation. Supporting optic nerve resilience requires stable oxygen delivery during sleep.

Supporting Mitochondrial Function

Retinal ganglion cells are energy-dependent neurons. Mitochondria help maintain axonal transport, membrane stability, calcium balance, and survival signaling. After ischemic stress, mitochondrial support becomes especially important. NRT may use nutrition, botanical compounds, metabolic optimization, sleep restoration, and stress reduction to support mitochondrial terrain. The language should remain cautious: these strategies support cellular resilience; they do not guarantee restoration of damaged optic nerve fibers.

Reducing Oxidative Stress Burden

Oxidative stress is one of the most important secondary injury pathways in ischemic neural tissue. NRT emphasizes antioxidant reserve through diet, lifestyle, and selected botanical or nutritional strategies. Traditional herbal medicine is increasingly studied through network pharmacology, systems biology, transcriptomics, and molecular pathway analysis. A single herb may contain many bioactive compounds, while a formula may contain hundreds of phytochemicals. These compounds may influence oxidative stress, inflammatory signaling, endothelial function, mitochondrial activity, and cellular survival pathways at the same time. This systems-level view fits the multifactorial biology of NAION, but individual claims must be supported by evidence and clinical judgment.

Supporting Inflammatory Balance

Ischemic injury often triggers glial activation and inflammatory signaling. NRT seeks to support inflammatory balance by addressing systemic drivers such as insulin resistance, poor sleep, gut inflammation, inflammatory diet patterns, stress physiology, and vascular disease. Traditional Chinese Medicine patterns such as Heat, Blood Stasis, Phlegm-Dampness, Liver Yang rising, or Qi Deficiency may be interpreted as clinical frameworks that overlap with inflammation, vascular congestion, metabolic dysregulation, autonomic stress, or low repair capacity. These parallels help patients understand traditional language without pretending that the systems are identical.

Supporting Neurotrophin Activity and Retinal Ganglion Cell Resilience

BDNF and NGF are involved in neuronal survival and repair. Optic nerve injury research has repeatedly explored neurotrophic factors as potential tools for retinal ganglion cell survival. In NRT, neurotrophin support means creating conditions that favor neural resilience: adequate perfusion, mitochondrial support, antioxidant defense, inflammatory balance, sleep quality, and stress regulation. Acupuncture, certain botanicals, movement, and nervous system regulation practices are sometimes discussed in relation to neurotrophic signaling, but NAION-specific human evidence remains limited.

Supporting Autonomic Balance

The autonomic nervous system helps regulate blood pressure, vascular tone, heart rate variability, and stress response. In NAION, autonomic instability may matter because the optic nerve is vulnerable to perfusion changes. NRT may emphasize breathing practices, sleep regularity, stress reduction, appropriate movement, and acupuncture-based approaches to help support a more stable neurovascular environment.

Supporting the Gut-Eye and Systemic Inflammatory Axis

Although the gut-eye axis is better studied in inflammatory and degenerative retinal diseases than in NAION specifically, systemic inflammation can influence vascular health, endothelial function, immune tone, and oxidative stress. NRT may evaluate digestion, nutrient absorption, inflammatory triggers, metabolic markers, and microbiome-related terrain when clinically appropriate. This is not because NAION is 'caused by the gut,' but because systemic inflammation can influence vascular and neural resilience throughout the body.

Supporting Whole-Person Risk Review

NAION is a warning event. It often points to broader vascular vulnerability. A whole-person review may include sleep quality, blood pressure patterns, glucose metabolism, lipid health, smoking exposure, anemia risk, hydration, stress load, medication timing questions for the prescribing physician, and cardiovascular history. NRT places the eye back into the body. The optic nerve is treated as part of a larger vascular-neural system.

Frequently Asked Questions on NAION

Selected References for Scientific Support

• Raizada K, Margolin E. Nonarteritic Anterior Ischemic Optic Neuropathy. StatPearls. Updated 2022. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK559045/
• Miller NR, Arnold AC. Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy. Eye. 2015;29:65-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC4289822/
• Salvetat ML, et al. Non-Arteritic Anterior Ischemic Optic Neuropathy (NA-AION). Journal of Clinical Medicine. 2023;7(4):72. https://pmc.ncbi.nlm.nih.gov/articles/PMC10661278/
• Bialer OY, et al. Evaluation and management of nonarteritic anterior ischemic optic neuropathy. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11458737/
• Liu B, Yu Y, Liu W, et al. Risk Factors for Non-arteritic Anterior Ischemic Optic Neuropathy: A Large Scale Meta-Analysis. Frontiers in Medicine. 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC8520961/
• Archer EL, Pepin S. Obstructive Sleep Apnea and Nonarteritic Anterior Ischemic Optic Neuropathy. Journal of Clinical Sleep Medicine. 2013. https://pmc.ncbi.nlm.nih.gov/articles/PMC3659384/
• Wu Y, Zhou LM, Lou H, Cheng JW, Wei RL. The Association Between Obstructive Sleep Apnea and Nonarteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis. Current Eye Research. 2016. https://pubmed.ncbi.nlm.nih.gov/26443989/
• Kang EYC, et al. Role of Oxidative Stress in Ocular Diseases Associated with Retinal Ganglion Cells Degeneration. Antioxidants. 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC8750806/
• Gokoffski KK, Peng M, Alas B, Lam P. Neuro-protection and Neuro-regeneration of the Optic Nerve. International Journal of Molecular Sciences. 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC8153234/
• Qin Y, et al. Clinical Efficacy Observation of Acupuncture Treatment for Nonarteritic Anterior Ischemic Optic Neuropathy. Evidence-Based Complementary and Alternative Medicine. 2015. https://pmc.ncbi.nlm.nih.gov/articles/PMC4458289/
• Weber AJ, et al. Combined application of BDNF to the eye and brain enhances retinal ganglion cell survival after optic nerve injury. Investigative Ophthalmology & Visual Science. 2010. https://pmc.ncbi.nlm.nih.gov/articles/PMC2869067/
• Chen H, Weber AJ. BDNF enhances retinal ganglion cell survival in cats with optic nerve injury. Investigative Ophthalmology & Visual Science. 2001. https://pubmed.ncbi.nlm.nih.gov/11274073/
• Xu L, et al. Inhibition of BDNF-AS Provides Neuroprotection for Retinal Ganglion Cells against Ischemic Injury. PLOS ONE. 2016. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0164941
• Buonfiglio F, et al. Reactive Oxygen Species in Optic Nerve Diseases. 2023 review. https://pdfs.semanticscholar.org/5f31/a2495974f61121f6681ec1ce77fbb8a9e6d5.pdf
• North American Neuro-Ophthalmology Society. Non-arteritic anterior ischemic optic neuropathy patient information. https://www.nanosweb.org/NAION/
• American Academy of Ophthalmology EyeWiki. Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION). Updated 2025. https://eyewiki.org/Non-Arteritic_Anterior_Ischemic_Optic_Neuropathy_%28NAION%29